Agritech New Zealand

agritechnz.org.nz

Launched in 2018, Agritech New Zealand is a purpose driven, membership funded organisation whose members share a passion for the opportunities that agritech can generate. Agritech New Zealand connects innovators, investors, regulators, researchers and interested public. It promotes opportunities and challenges raised by agritech.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Research

KINETA AND SAMSUNG BIOLOGICS ANNOUNCE ANTI-VISTA ANTIBODY IMMUNOTHERAPY DEVELOPMENT AND MANUFACTURING AGREEMENT

Samsung Biologics | July 21, 2021

news image

Kineta, Inc., a clinical-stage biotech firm developing novel immunotherapies in oncology, has signed a strategic partnership agreement with Samsung Biologics, one of the world's top contract development and manufacturing companies (CDMO). To support the IND filing for KVA12.1, Kineta's new anti-VISTA antibody under development to treat solid tumors, Samsung Biologics will offer end-through-end CDMO services ranging from cell line development to cell line development clinical drug substan...

Read More

AVM BIOTECHNOLOGY HIRES EXECUTIVE TEAM FOR ONCOLOGY & COVID-19 CLINICAL TRIALS

AVM Biotechnology | July 09, 2020

news image

Seattle's AVM Biotechnology, an up-and-coming biotech firm whose lead molecule, AVM0703, has received FDA permission to begin clinical trials treating no-option Non-Hodgkin's Lymphoma and is applying to begin trials treating moderate-severely ill COVID-19 patients, announced today the hiring of Janet R. Rea, MSPH, as Chief Operating Officer. As COO, Rea will lead operations and direct regulatory affairs as the company conducts clinical trials and brings AVM0703 to market."I am...

Read More

Medical

NOVAVAX SUBMITS REQUEST TO THE U.S. FDA FOR EMERGENCY USE AUTHORIZATION OF COVID-19 VACCINE

Novavax, Inc. | January 31, 2022

news image

Novavax, Inc. a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that it has submitted a request to the U.S Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) for NVX-CoV2373, its protein-based COVID-19 vaccine candidate for immunization of individuals 18 year of age and older against SARS-CoV-2. The request for EUA is based on the totality of pre-clinical, clinical and...

Read More

Medical

SELFDECODE OFFERS FREE KIDNEY HEALTH DNA REPORT TO CELEBRATE NATIONAL KIDNEY MONTH

SELFDECODE | March 07, 2022

news image

SelfDecode is kicking off National Kidney Month with a national campaign to raise awareness about the importance of preventative measures to optimize kidney health. For the month of March, SelfDecode is offering a free Kidney Health DNA Report to anyone who uploads a DNA file for analysis. Through genetic testing, SelfDecode is providing people with the opportunity to gain insight regarding their genetic predisposition for health issues and receive personalized recommendations to ...

Read More
news image

Research

KINETA AND SAMSUNG BIOLOGICS ANNOUNCE ANTI-VISTA ANTIBODY IMMUNOTHERAPY DEVELOPMENT AND MANUFACTURING AGREEMENT

Samsung Biologics | July 21, 2021

Kineta, Inc., a clinical-stage biotech firm developing novel immunotherapies in oncology, has signed a strategic partnership agreement with Samsung Biologics, one of the world's top contract development and manufacturing companies (CDMO). To support the IND filing for KVA12.1, Kineta's new anti-VISTA antibody under development to treat solid tumors, Samsung Biologics will offer end-through-end CDMO services ranging from cell line development to cell line development clinical drug substan...

Read More
news image

AVM BIOTECHNOLOGY HIRES EXECUTIVE TEAM FOR ONCOLOGY & COVID-19 CLINICAL TRIALS

AVM Biotechnology | July 09, 2020

Seattle's AVM Biotechnology, an up-and-coming biotech firm whose lead molecule, AVM0703, has received FDA permission to begin clinical trials treating no-option Non-Hodgkin's Lymphoma and is applying to begin trials treating moderate-severely ill COVID-19 patients, announced today the hiring of Janet R. Rea, MSPH, as Chief Operating Officer. As COO, Rea will lead operations and direct regulatory affairs as the company conducts clinical trials and brings AVM0703 to market."I am...

Read More
news image

Medical

NOVAVAX SUBMITS REQUEST TO THE U.S. FDA FOR EMERGENCY USE AUTHORIZATION OF COVID-19 VACCINE

Novavax, Inc. | January 31, 2022

Novavax, Inc. a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that it has submitted a request to the U.S Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) for NVX-CoV2373, its protein-based COVID-19 vaccine candidate for immunization of individuals 18 year of age and older against SARS-CoV-2. The request for EUA is based on the totality of pre-clinical, clinical and...

Read More
news image

Medical

SELFDECODE OFFERS FREE KIDNEY HEALTH DNA REPORT TO CELEBRATE NATIONAL KIDNEY MONTH

SELFDECODE | March 07, 2022

SelfDecode is kicking off National Kidney Month with a national campaign to raise awareness about the importance of preventative measures to optimize kidney health. For the month of March, SelfDecode is offering a free Kidney Health DNA Report to anyone who uploads a DNA file for analysis. Through genetic testing, SelfDecode is providing people with the opportunity to gain insight regarding their genetic predisposition for health issues and receive personalized recommendations to ...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us